Skip to content

The effect of Acemannan in implant placement with simultaneous bone graft in esthetic zone : A randomized controlled trial

The effect of Acemannan in implant placement with simultaneous bone graft in esthetic zone : A randomized controlled trial

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20191002002
Enrollment
Unknown
Registered
2019-10-02
Start date
2019-10-02
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Single edentulous tooth patient who requires implant placement in esthetic zone &#45

Interventions

Xenograft ,Xenograft with Acemannan 50 mg.
Placebo Comparator Biological/Vaccine,Experimental Biological/Vaccine
Xenograft,Xenograft with Acemannan

Sponsors

Graduate school, Chulalongkorn University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patient who has single edentulous area and can achieve appropriate 3 dimensional positions of implant placement in esthetic zone. 2. Patient with age ≥ 20 years old. 3. Patient who has mild to moderate atrophy of bone. ( loss of 25-50% bone width and bone height from radiograph ) 4. Patient with sufficient keratinized gingiva. 5. Patient who are healthy or well-controlled systemic disease.

Exclusion criteria

Exclusion criteria: 1. Patient who had previously received bone graft on the site to be operated. 2. Smokers. 3. Patient with poor plaque control and untreated chronic periodontitis. 4. Patient with acute infection such as severe swelling, suppuration and abscess. 5. Patient who is pregnant or lactating. 6. Patient who has previously received radiation therapy in head and neck regions. 7. Patient who has received chemotherapy.

Design outcomes

Primary

MeasureTime frame
bone formation mmediate post-operative, post-operative 3 months, and post-operative 6 months measure in clinic and radiograph

Secondary

MeasureTime frame
Size of outbreaks of HFMD in childcare centers/kindergartens in treatment versus control arms. 1 year Incidence of outbreak,Association of low serum vitamin A level and severity of HFMD in both arms 1 year Odds ratio

Countries

Thailand

Contacts

Public ContactPornchai Jansisyanont

Faculty of Dentistry, Chulalongkorn University

Jpornchai@hotmail.com0899209260

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026